SCHEMBL6322925

SCHEMBL6322925

Cc1ccc(S(=O)(=O)OC2C3CNCC3CN2c2cnc(-c3ccccc3)nc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
MAPK1 P28482 1/20 0.37
CHRNB2 P17787 3/20 0.36
CHRNA4 P43681 3/20 0.36
CYP1A2 P05177 2/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
CHRNA7 P36544 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
HSD11B1 P28845 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GBA1 P04062 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MCL1 Q07820 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL929655 0.83 USP30 (0.39) ALDH1A1MAPK1CYP1A2CYP2D6CYP3A4
SCHEMBL929129 0.83 FAAH (0.38) ALDH1A1MAPK1CYP1A2NR1H2NR1H3
SCHEMBL928239 0.82 CYP2D6 (0.35) ALDH1A1CHRNB2CHRNA4CYP1A2CYP2D6
SCHEMBL928152 0.79 MEN1 (0.41) ALDH1A1MAPK1MEN1KMT2AKDM4E
SCHEMBL928386 0.79 NPC1 (0.35) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL928612 0.79 CYP2D6 (0.35) CHRNA4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL6332378 0.77 ALDH1A1 (0.41) ALDH1A1MAPK1CHRNB2CHRNA4CYP1A2
SCHEMBL1794096 0.76 CYP2D6 (0.35) ALDH1A1CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL6322920 0.74 CHRNB2 (0.50) ALDH1A1MAPK1CHRNB2CHRNA4CYP1A2
SCHEMBL1792844 0.71 CHRNB2 (0.43) ALDH1A1CHRNB2CHRNA4CYP1A2CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065178-A1 Substituted diazabicycloakane derivatives ABBOTT LABORATORIES 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065178-A1 Substituted diazabicycloakane derivatives CHRNA7, CHRNA1, CHRNA5 ALDH1A1 537/4885MAPK1 1830/4885CHRNB2 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.